跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAXALT MAX 10 mg LIOFILIZADO ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MAXALT MAX 10 mg LIOFILIZADO ORAL
Approved
STANDARD
MAXALT MAX 10 mg LIOFILIZADO ORAL
Organon France
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 15, 2021
Approval ID
7055121192a63353
Company
Organon France
Type
Standard
Approval Details
Approval Id
7055121192a63353
Drug Cima Aemps Name
MAXALT MAX 10 mg LIOFILIZADO ORAL
Register Number
3400934794346
Holder Company Name
Organon France
Marketing Company Name
Euromed Pharma Spain S.L.
Authorization Date
2021-12-15
Dosage Form
LIOFILIZADO ORAL
Dose
10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Organon France
Active Ingredients
RIZATRIPTAN BENZOATO
14,530 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 15, 2021
Approval ID
7055121192a63353
Type
Standard
Back to CIMA-AEMPS Approvals